United States - MEX-AD:Clinical, epidemiological, & genetic characterization of Alzheimer's patients in the admixed Mexican population
For more information and to make a bid you will need to go to the third party website.
Details
Provided by
- Opportunity closing date
- 26 February 2024
- Opportunity publication date
- 12 January 2024
- Value of contract
- to be confirmed
- Your guide to exporting
Description
The purpose of this requirement is to establish a multicentre cohort study in Mexico and characterize Alzheimer's
disease (AD) patients' clinical, genetic, and phenotypic diversity in the admixed Mexican population, a group with
unique genetic admixture and environmental exposures that is underrepresented in AD research.
First, the Contractor shall determine the genetic substructure and familial contributions to AD in Mexico. This will
advance efforts to treat AD in patients with rare mutations.
Second, by assembling this large cohort, the Contractor shall work to establish a preliminary Mexican-specific
polygenic risk score (PRS) for predicting AD risk in future samples.
Please see attached RFP titled "75N95024R00016 Solicitation" for the full solicitation.
- Opportunity closing date
- 26 February 2024
- Value of contract
- to be confirmed
About the buyer
- Address
- NATIONAL INSTITUTES OF HEALTH NIDA UNITED STATES
- Contact
- hashim.dasti@nih.gov
The deadline to apply for this opportunity has passed.
Visit the
opportunities page
to find another.